Luca Issi
Stock Analyst at RBC Capital
(0.56)
# 3,996
Out of 4,442 analysts
657
Total ratings
38.2%
Success rate
-1.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $445 | $288.18 | +54.42% | 63 | Jun 18, 2026 | |
| AMGN Amgen | Reiterated: Buy | $370 | $347.01 | +6.63% | 10 | Jun 18, 2026 | |
| QURE uniQure | Maintained: Buy | $35 → $65 | $49.04 | +32.54% | 43 | Jun 18, 2026 | |
| FULC Fulcrum Therapeutics | Maintained: Hold | $10 → $4 | $3.85 | +3.90% | 6 | Jun 2, 2026 | |
| ARGX argenx SE | Maintained: Buy | $890 | $853.40 | +4.29% | 10 | May 27, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | n/a | $812.00 | - | 1 | May 27, 2026 | |
| SGMO Sangamo Therapeutics, Inc. | Maintained: Hold | $2 | $0.074 | +2,602.70% | 21 | May 14, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $19 | $9.95 | +90.95% | 39 | May 14, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $9 | $2.07 | +334.78% | 32 | May 13, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Hold | $15 | $15.25 | -1.64% | 36 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $20.26 | +48.08% | 11 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.92 | +306.50% | 14 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $13.71 | -41.65% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $33.20 | -21.69% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.66 | +502.41% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $87 | $79.90 | +8.89% | 38 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $275 | $238.59 | +15.26% | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $68.63 | +45.71% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $28.76 | +21.70% | 18 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $2.76 | +44.93% | 26 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $66 | $56.50 | +16.81% | 35 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 | $53.99 | -7.39% | 29 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $38 | $61.00 | -37.70% | 37 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $100 | $75.99 | +31.60% | 39 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $35.59 | -21.33% | 6 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $6.04 | +148.34% | 27 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $11.81 | n/a | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $54 | $11.88 | n/a | 13 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $5.75 | n/a | 7 | Mar 21, 2023 |
Alnylam Pharmaceuticals
Jun 18, 2026
Maintained: Buy
Price Target: $445
Current: $288.18
Upside: +54.42%
Amgen
Jun 18, 2026
Reiterated: Buy
Price Target: $370
Current: $347.01
Upside: +6.63%
uniQure
Jun 18, 2026
Maintained: Buy
Price Target: $35 → $65
Current: $49.04
Upside: +32.54%
Fulcrum Therapeutics
Jun 2, 2026
Maintained: Hold
Price Target: $10 → $4
Current: $3.85
Upside: +3.90%
argenx SE
May 27, 2026
Maintained: Buy
Price Target: $890
Current: $853.40
Upside: +4.29%
argenx SE
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $812.00
Upside: -
Sangamo Therapeutics, Inc.
May 14, 2026
Maintained: Hold
Price Target: $2
Current: $0.074
Upside: +2,602.70%
REGENXBIO
May 14, 2026
Maintained: Buy
Price Target: $19
Current: $9.95
Upside: +90.95%
Allogene Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $9
Current: $2.07
Upside: +334.78%
Intellia Therapeutics
May 11, 2026
Maintained: Hold
Price Target: $15
Current: $15.25
Upside: -1.64%
May 11, 2026
Reiterated: Buy
Price Target: $30
Current: $20.26
Upside: +48.08%
May 11, 2026
Maintained: Buy
Price Target: $20
Current: $4.92
Upside: +306.50%
May 8, 2026
Maintained: Hold
Price Target: $8
Current: $13.71
Upside: -41.65%
May 8, 2026
Maintained: Hold
Price Target: $26
Current: $33.20
Upside: -21.69%
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $1.66
Upside: +502.41%
May 7, 2026
Maintained: Buy
Price Target: $80 → $87
Current: $79.90
Upside: +8.89%
May 7, 2026
Maintained: Buy
Price Target: $275
Current: $238.59
Upside: +15.26%
May 7, 2026
Maintained: Buy
Price Target: $100
Current: $68.63
Upside: +45.71%
May 5, 2026
Reiterated: Buy
Price Target: $35
Current: $28.76
Upside: +21.70%
May 5, 2026
Maintained: Hold
Price Target: $4
Current: $2.76
Upside: +44.93%
May 4, 2026
Maintained: Hold
Price Target: $66
Current: $56.50
Upside: +16.81%
May 4, 2026
Maintained: Hold
Price Target: $50
Current: $53.99
Upside: -7.39%
May 1, 2026
Maintained: Hold
Price Target: $35 → $38
Current: $61.00
Upside: -37.70%
Apr 29, 2026
Maintained: Buy
Price Target: $95 → $100
Current: $75.99
Upside: +31.60%
Apr 29, 2026
Maintained: Hold
Price Target: $28
Current: $35.59
Upside: -21.33%
Apr 28, 2026
Maintained: Buy
Price Target: $15
Current: $6.04
Upside: +148.34%
Nov 13, 2024
Maintained: Buy
Price Target: $9 → $11
Current: $11.81
Upside: n/a
May 11, 2023
Maintained: Hold
Price Target: $3 → $54
Current: $11.88
Upside: n/a
Mar 21, 2023
Maintained: Hold
Price Target: $4 → $3
Current: $5.75
Upside: n/a